Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Kazia Therapeutics Limited/ADR/ 424B3

SEC Filing · 424B3

Kazia Therapeutics Limited/ADR

SEC Filing

Filed Oct 16, 2024Accepted Oct 16, 2024, 12:16 PM EDTCIK 1055886Accession 0001019155-24-000301
View company →Permanent SEC source ↗
Share

Recent company filings

  1. EFFECT filingSep 25, 2026
  2. F-6 filingSep 18, 2026
  3. 424B3 filingApr 4, 2025
  4. 424B3 filingOct 16, 2024
  5. 424B3 filingOct 16, 2024

As-filed source

Primary evidence
As filedOpen full document ↗